The global Maternal Mental Health Market is expanding as healthcare providers, insurers, employers, and maternal-care organizations increasingly recognize the importance of mental health during pregnancy and the postpartum period. Growing awareness of postpartum depression, pregnancy-related anxiety, dysthymia, and birth-related PTSD is encouraging earlier screening and treatment. Healthcare systems are increasingly integrating behavioral-health assessments into prenatal, obstetric, primary-care, and postpartum services.
According to Fortune Business Insights, the global Maternal Mental Health Market was valued at USD 7.40 billion in 2025 and is projected to grow from USD 7.96 billion in 2026 to USD 14.33 billion by 2034, exhibiting a CAGR of 7.63% during the forecast period.
Why is the Maternal Mental Health Market Growing?
Increasing recognition and screening of maternal mental-health conditions are major factors supporting market growth. Hospitals and obstetric practices are adopting standardized assessments, referral systems, psychotherapy, telehealth, digital therapeutics, and medication-management services. Digital maternal-health platforms are also improving access for women facing geographic, childcare, transportation, or scheduling barriers. The U.S. market has received additional attention following the 2023 FDA approval of oral zuranolone, creating a dedicated pharmaceutical treatment pathway for postpartum depression.
Key Market Trends Shaping Industry Growth
Increasing Focus on Early Screening and Prevention
Healthcare organizations are shifting from reactive treatment toward earlier identification of depression, anxiety, and trauma-related conditions during pregnancy and after childbirth.
Growing Adoption of Digital Maternal Care
Digital platforms are combining screening, education, mood tracking, therapy content, referrals, and remote care within integrated maternal-health experiences.
Expansion of Telehealth Services
Virtual consultations and telepsychiatry are improving access to behavioral-health professionals, particularly for rural and underserved populations.
Increasing Pharmaceutical Innovation
New therapies specifically designed for postpartum depression are expanding treatment options and strengthening pharmaceutical interest in maternal mental health.
Growing Focus on Personalized and Culturally Responsive Care
Providers are increasingly considering social determinants, pregnancy history, birth experiences, financial stress, and individual patient circumstances when designing maternal mental-health pathways.
Market Dynamics
Driver: Increasing Recognition and Screening of Perinatal Mental Health Conditions
Greater awareness of maternal depression, anxiety, and trauma is encouraging healthcare providers to integrate screening into prenatal and postpartum pathways. This is creating demand for assessment tools, behavioral-health professionals, telepsychiatry, digital platforms, and specialized therapeutic programs.
Restraint: Limited Access to Specialized Providers and Uneven Reimbursement
A shortage of professionals trained in perinatal mental health can create long waiting periods and restrict access. Uneven reimbursement for therapy, digital interventions, medication management, and care navigation can also slow adoption.